Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with ...

Three poster presentations at the San Antonio Breast Cancer Symposium (December 10, 2025) will highlight positive Phase 2 ...

The Center for Bioenergy Innovation (CBI), a Department of Energy Bioenergy Research Center at Oak Ridge National Laboratory, ...

Department of Soil and Crop Sciences faculty and students received national honors at the Science Societies annual meeting in ...

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an ...

Prothena (PRTA) “announced a scientific presentation at Neuroscience 2025, hosted by the Society for Neuroscience in San Diego, CA. CYTOPE is a ...

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced a ...

Nearly eight months after Kanzi, the celebrated bonobo at Des Moines’ Ape Cognition and Conservation Initiative, died more than 150 people came together to honor his life and legacy. The gathering, ...

The MarketWatch News Department was not involved in the creation of this content. NATICK, Mass., Oct. 23, 2025 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine(TM), announced ...

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea “Nearly 2 million ...

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea LivaNova PLC (Nasdaq: ...

Company studies continue to show durability and retention of benefits for patients receiving proximal hypoglossal nerve stimulation for moderate to severe obstructive sleep apnea LONDON, October 07, ...